Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00599131 · MORE INFO

Limitations, agreements, and source contact

Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) · Source last updated 2015-12-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The study was discontinued prematurely due to an early stopping rule.
point Of Contact
email
fworden@umich.edu
organization
University of Michigan Comprehensive Cancer Center
phone
734-936-0453
title
Dr. Francis Worden
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The study was discontinued prematurely due to an early stopping rule.
point Of Contact
email
fworden@umich.edu
organization
University of Michigan Comprehensive Cancer Center
phone
734-936-0453
title
Dr. Francis Worden

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice